medi7510
Vaccineexperimental
Clinical trial activity
3 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2014 (NCT02115815)
Timeline
Indications
Mechanism of action
- RSV F-proteinImmunity, active
RSV F-protein immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- medi7510
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02508194 | Phase 2 | Sep 1, 2015 | MedImmune |
| NCT02289820 | Phase 1 | Jan 1, 2015 | Compass Research, MedImmune, MRA Clinical Research, The Center for Pharmaceutical Research, Vanderbilt University, Wake Research Associates |
| NCT02115815 | Phase 1 | Apr 1, 2014 | Accelovance, Compass Research, MedImmune, MRA Clinical Research |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MedImmune | For profit | 3 | 3 | 2 | 2014 |
| Compass Research | For profit | 2 | 0 | 1 | 2014 |
| MRA Clinical Research | Academic/Hospital | 2 | 0 | 1 | 2014 |
| Accelovance | For profit | 1 | 0 | 1 | 2014 |
| The Center for Pharmaceutical Research | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Wake Research Associates | For profit | 1 | 0 | 1 | 2015 |
7 organizations
Page 1 / 1